Paper
Organic & Biomolecular Chemistry
7.9 min (major enantiomer) and 8.9 min (minor enantiomer);
(1R,2S,3S)-Methyl 2-(4-chlorophenyl)-3-methyl-3-nitro-4-oxo-
δH (400 MHz, CDCl3): 8.22 (1 H, d, J = 8.0), 7.67 (1 H, app t), 1,2,3,4-tetrahydronaphthalene-1-carboxylate (trans-19a, Table 4,
7.53 (1 H, app t), 7.38–7.31 (4 H, m), 7.29–7.22 (2 H, m), entry 3). Prepared according to the consecutive use of general
4.82 (1 H, d, J = 12.3), 4.58 (1 H, d, J = 12.3), 3.57 (3 H, s), procedures
1.72 (3 H, s); δC (100 MHz, CDCl3): 189.9, 171.0, 138.9, 135.4, (48.6 mg, 0.246 mmol) and anhydride
C
and D, using β-methyl-(E)-nitroalkene 17b
(39.9 mg,
1
133.3, 129.6, 129.2, 129.1, 129.07, 129.0, 128.8, 127.3, 97.0, 0.246 mmol). Upon epimerisation, the reaction gave a diaster-
52.8, 50.3, 48.9, 16.2; νmax (neat)/cm−1: 3008, 2955, 1732, 1692, eomeric mixture of esters in a >98 : 2 (trans : cis) ratio. The
1598, 1550, 1453, 1345, 1211, 1166, 970, 794, 733, 700; HRMS major diastereomer (trans-19a) was purified by flash column
(m/z – ESI): Found: 338.1027 (M − H)− C19H16NO5 requires: chromatography, eluting in gradient from 100% hexanes to
338.1028.
20% EtOAc in hexanes, to give a white solid (85.6 mg, 93%).
(1S,2S,3S)-Methyl
3-methyl-3-nitro-4-oxo-2-phenyl-1,2,3,4- M.p. 200–202 °C; TLC (hexanes : EtOAc, 8 : 2 v/v): Rf = 0.24;
tetrahydronaphthalene-1-carboxylate (cis-13b, Table 3, entry 1). [α]2D0 = +88.5 (c = 0.20, CHCl3); CSP-HPLC analysis. Chiralpak
Prepared according to general procedure C using catalyst 15 AD-H (4.6 mm × 25 cm), hexane/IPA: 95/5, 1.0 mL min−1, RT,
(5.8 mg, 0.0123 mmol – 5 mol%). The cis-diastereomer (cis- UV detection at 254 nm, retention times: trans-19a 19.9 min
13b) was purified by flash column chromatography, eluting in (minor enantiomer) and 38.8 min (major enantiomer); cis-19b
gradient from 100% hexanes to 20% EtOAc in hexanes, to give 8.7 min (major enantiomer) and 9.7 min (minor enantiomer);
a white solid. M.p. 76–78 °C; TLC (hexanes : EtOAc, 8 : 2 v/v): δH (400 MHz, CDCl3): 8.22 (1 H, d, J = 7.2), 7.68 (1 H, app. t),
Rf = 0.39; [α]2D0 = −76.4 (c = 0.10, CHCl3); CSP-HPLC analysis: 7.54 (1 H, app. t), 7.38–7.29 (3 H, m), 7.21 (2 H, d, J = 6.8), 4.81
Chiralpak AD-H (4.6 mm × 25 cm), hexane/IPA: 95/5, 1.0 mL (1 H, d, J = 12.3), 4.52 (1 H, d, J = 12.3), 3.60 (3 H, s), 1.70 (3 H,
min−1, RT, UV detection at 254 nm, retention times: cis-13b s); δC (100 MHz, CDCl3): 189.5, 170.8, 138.5, 135.8, 135.2,
7.6 min (major enantiomer) and 8.6 min (minor enantiomer); 131.8, 130.5, 129.7, 129.4, 129.2, 128.7, 127.3, 96.8, 52.9, 49.7,
δH (400 MHz, CDCl3): 8.18 (1 H, d, J = 7.8), 7.65 (1 H, app. t), 48.8, 16.1; νmax (neat)/cm−1: 3001, 2956, 2924, 2851, 1741,
7.52 (1 H, app. t), 7.42 (1 H, d, J = 7.9), 7.22–7.26 (1 H, m), 7.18 1698, 1596, 1550, 1491, 1438, 1290, 1255, 1166, 1091, 1004,
(2 H, app. t), 6.97 (2 H, d, J = 7.4), 4.66 (1 H, d, J = 6.2), 4.58 844, 795, 740; HRMS (m/z – ESI): Found: 372.0639 (M − H)−
(1 H, d, J = 6.2), 3.45 (3 H, s), 1.64 (3 H, s); δC (100 MHz, C19H15NO5Cl requires: 372.0639.
CDCl3): 187.5, 170.8, 136.9, 134.6, 133.7, 132.2, 130.8, 129.6,
(1R,2S,3S)-Methyl
2-(4-methoxyphenyl)-3-methyl-3-nitro-
129.1, 128.9, 128.5, 128.2, 93.3, 53.1, 52.3, 46.1, 21.7; νmax 4-oxo-1,2,3,4-tetrahydronaphthalene-1-carboxylate (trans-20a,
(neat)/cm−1: 3004, 2952, 1743, 1701, 1599, 1542, 1457, 1298, Table 4, entry 4). Prepared according to the consecutive use of
1200, 1179, 1003, 941, 816, 765, 705; HRMS (m/z – ESI): Found: general procedures C and D, using β-methyl-(E)-nitroalkene
338.1026 (M − H)− C19H16NO5 requires: 338.1028.
17c (47.5 mg, 0.246 mmol) and anhydride 1 (39.9 mg,
(1R,2S,3S)-Methyl 3-methyl-3-nitro-4-oxo-1,2,3,4-tetrahydro- 0.246 mmol). Upon epimerisation, the reaction gave a diastereo-
[2,2′-binaphthalene]-1-carboxylate (trans-18a, Table 4, entry 2). meric mixture of esters in a 96 : 4 (trans : cis) ratio. The
Prepared according to the consecutive use of general pro- major diastereomer (trans-20a) was purified by flash column
cedure C and D, using β-methyl-(E)-nitroalkene 17a (52.5 mg, chromatography, eluting in gradient from 100% hexanes to
0.246 mmol) and anhydride 1 (39.9 mg, 0.246 mmol). Upon 20% EtOAc in hexanes, to give a white solid (83.2 mg, 92%).
epimerisation, the reaction gave a diastereomeric mixture of M.p. 193–195 °C; TLC (hexanes : EtOAc, 8 : 2 v/v): Rf = 0.17;
esters in a >99 : 1 (trans : cis) ratio. The major diastereomer [α]2D0 = +81.0 (c = 0.10, CHCl3); CSP-HPLC analysis: Chiralpak
(trans-18a) was purified by flash column chromatography, AD-H (4.6 mm × 25 cm), hexane/IPA: 95/5, 1.0 mL min−1, RT,
eluting in gradient from 100% hexanes to 20% EtOAc in UV detection at 254 nm, retention times: trans-20a 22.7 min
hexanes, to give
a
white solid (88.7 mg, 93%). M.p. (minor enantiomer) and 41.0 min (major enantiomer); cis-20b
10.9 min (major enantiomer) and 12.2 min (minor enantio-
205–207 °C; TLC (hexanes : EtOAc, 8 : 2 v/v): Rf = 0.21; [α]D20
=
+116.3 (c = 0.10, CHCl3); CSP-HPLC analysis: Chiralcel OD-H mer); δH (400 MHz, CDCl3): 8.21 (1 H, d, J = 7.9), 7.66 (1 H,
(4.6 mm × 25 cm), hexane/IPA: 95/5, 1.0 mL min−1, RT, UV app. t), 7.52 (1 H, app. t), 7.32 (1 H, d, J = 7.8), 7.18 (2 H, d, J =
detection at 254 nm, retention times: trans-18a 19.8 min 8.2), 6.86 (2 H, d, J = 8.2), 4.76 (1 H, d, J = 12.4), 4.52 (1 H, d,
(minor enantiomer) and 22.6 min (major enantiomer); cis-18b J = 12.4), 3.79 (3 H, s), 3.58 (3 H, s), 1.70 (3 H, s); δC (100 MHz,
10.5 min (major enantiomer) and 11.5 min (minor enantio- CDCl3): 190.1, 171.1, 159.9, 139.0, 135.6, 130.3, 129.6, 129.0,
mer); δH (400 MHz, CDCl3): 8.25 (1 H, d, J = 7.9), 7.87–7.79 128.9, 127.3, 125.1, 114.4, 97.2, 55.3, 52.8, 49.7, 49.1, 16.1;
(3 H, m), 7.74 (1 H, s), 7.69 (1 H, app. t), 7.59–7.47 (3 H, m), νmax (neat)/cm−1: 3000, 2960, 2927, 2849, 1739, 1693, 1595,
7.37 (2 H, app. d), 5.0 (1 H, d, J = 12.2), 4.72 (1 H, d, J = 12.2), 1550, 1513, 1438, 1385, 1344, 1294, 1250, 1182, 1107, 1027,
3.52 (3 H, s), 1.78 (3 H, s); δC (100 MHz, CDCl3): 189.9, 171.0, 837, 796, 737; HRMS (m/z – ESI): Found: 368.1147 (M − H)−
138.9, 135.7, 133.4, 133.3, 130.8, 129.7, 129.1, 128.9 (2C), C20H18NO6 requires: 368.1134.
128.8, 128.4, 127.8, 127.3, 126.9, 126.7, 126.3, 97.1, 52.9, 50.4,
(1R,2R,3S)-Methyl 2-(furan-2-yl)-3-methyl-3-nitro-4-oxo-1,2,3,4-
49.0, 16.4; νmax (neat)/cm−1: 3063, 3029, 3009, 2955, 2924, tetrahydronaphthalene-1-carboxylate (trans-21a, Table 4, entry 5).
2850, 1729, 1691, 1599, 1548, 1392, 1346, 1289, 1201, 1159, Prepared according to the consecutive use of general pro-
968, 820, 733; HRMS (m/z – ESI): Found: 388.1194 (M − H)− cedures C and D, using β-methyl-(E)-nitroalkene 17d (37.7 mg,
C23H18NO5 requires: 388.1185.
0.246 mmol) and anhydride 1 (39.9 mg, 0.246 mmol). Upon
Org. Biomol. Chem.
This journal is © The Royal Society of Chemistry 2017